Paul Hudson – Talk Bio

Actionable Insights Powered by AI

JPM26 Day 3: Sanofi CEO on RSV Scrutiny and Regeneron Dupixent Defense

8 hours ago talkbio0Tagged Beyfortus, Dupixent, JPM26, Paul Hudson, Regeneron, Respiratory syncytial virus, sanofi, United States Food and Drug Administration, Vaccines

JPM26; Sanofi; RSV; Beyfortus; Paul Hudson; FDA; vaccines; Dupixent; Regeneron